Stacy Ku
Stock Analyst at TD Cowen
(0.73)
# 3,994
Out of 5,054 analysts
6
Total ratings
50%
Success rate
-14.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stacy Ku
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $45 → $60 | $45.40 | +32.16% | 1 | Oct 23, 2025 | |
| BCRX BioCryst Pharmaceuticals | Reinstates: Buy | $30 | $7.20 | +316.67% | 1 | Oct 15, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | n/a | $22.26 | - | 1 | Jan 7, 2025 | |
| KALV KalVista Pharmaceuticals | Initiates: Buy | $30 | $10.89 | +175.48% | 1 | Jan 7, 2025 | |
| VRCA Verrica Pharmaceuticals | Maintains: Buy | $150 → $100 | $3.87 | +2,483.98% | 1 | Oct 21, 2024 | |
| ATXS Astria Therapeutics | Initiates: Buy | $35 | $12.61 | +177.56% | 1 | Jul 29, 2024 |
Supernus Pharmaceuticals
Oct 23, 2025
Maintains: Buy
Price Target: $45 → $60
Current: $45.40
Upside: +32.16%
BioCryst Pharmaceuticals
Oct 15, 2025
Reinstates: Buy
Price Target: $30
Current: $7.20
Upside: +316.67%
Centessa Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: n/a
Current: $22.26
Upside: -
KalVista Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $30
Current: $10.89
Upside: +175.48%
Verrica Pharmaceuticals
Oct 21, 2024
Maintains: Buy
Price Target: $150 → $100
Current: $3.87
Upside: +2,483.98%
Astria Therapeutics
Jul 29, 2024
Initiates: Buy
Price Target: $35
Current: $12.61
Upside: +177.56%